Indoleamine 2,3 dioxygenase and metabolic control of immune responses

Munn, David H., Mellor, Andrew L.·2013·Trends in Immunology

Cited by (1,000)

Items 301–400 of 1,000

  1. What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
    Yao Yu, Heng Liang, Xin Fang, Shengnan Zhang, Zikang Xing, Lei Shi, Chunxiang Kuang, Barbara Seliger, Qing Yang · 2021 · Journal of Experimental & Clinical Cancer Research
  2. AhR diminishes the efficacy of chemotherapy via suppressing STING dependent type-I interferon in bladder cancer
    Zikun Ma, Zhiyong Li, Yize Mao, Jingwei Ye, Zefu Liu, Yuzhao Wang, Chen Wei, Jun Cui, Zhuowei Liu, Xiaoyu Liang · 2023 · Nature Communications
  3. Local and long-range activation of innate immunity by infection and damage in C. elegans
    Jonathan J. Ewbank, Nathalie Pujol · 2015 · Current Opinion in Immunology
  4. Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer
    Tao Zhang, Xiang-Long Tan, Yong Xu, Zizheng Wang, Chaohui Xiao, Rong Liu · 2017 · Chinese Medical Journal
  5. Prognostic implications of tumor-infiltrating macrophages, M2 macrophages, regulatory T-cells, and indoleamine 2,3-dioxygenase-positive cells in primary diffuse large B-cell lymphoma of the central nervous system
    Soo Jeong Nam, Sehui Kim, Dohee Kwon, Hannah Kim, Soyeon Kim, Eunyoung Lee, Tae Min Kim, Dae Seog Heo, Sung‐Hye Park, Megan S. Lim et al. · 2018 · OncoImmunology
  6. Metabolic biomarkers for chronic kidney disease
    Marc Breit, Klaus M. Weinberger · 2015 · Archives of Biochemistry and Biophysics
  7. Endothelial cell and T‐cell crosstalk: Targeting metabolism as a therapeutic approach in chronic inflammation
    Michelangelo Certo, Hagar Elkafrawy, Valentina Pucino, Danilo Cucchi, Kenneth Chat-Pan Cheung, Claudio Mauro · 2020 · British Journal of Pharmacology
  8. Indoleamine‐2,3‐dioxygenase as an effector and an indicator of protective immune responses in patients with acute hepatitis B
    Sachiyo Yoshio, Masaya Sugiyama, Hirotaka Shoji, Yohei Mano, Eiji Mita, Toru Okamoto, Yoshiharu Matsuura, Alato Okuno, Osamu Takikawa, Masashi Mizokami et al. · 2015 · Hepatology
  9. Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin
    Saman Maleki Vareki, Mateusz Rytelewski, René Figueredo, Di Chen, Peter J. Ferguson, Mark David Vincent, Wei‐Ping Min, Xiufen Zheng, James D. Koropatnick · 2014 · Oncotarget
  10. Mesenchymal-myeloid interaction in the regulation of immunity
    Tik Shing Cheung, Francesco Dazzi · 2018 · Seminars in Immunology
  11. Indoleamine 2,3-dioxygenase in endometrial cancer: a targetable mechanism of immune resistance in mismatch repair-deficient and intact endometrial carcinomas
    Anne M. Mills, Sara L. Zadeh, Emily A. Sloan, Zachary Chinn, Susan C. Modesitt, Kari Lassen Ring · 2018 · Modern Pathology
  12. Modulatory Effects of Pregnancy on Inflammatory Bowel Disease
    Janine van der Giessen, Vivian Huang, C. Janneke van der Woude, Gwenny Manel Fuhler · 2019 · Clinical and Translational Gastroenterology
  13. Trial Watch—Small molecules targeting the immunological tumor microenvironment for cancer therapy
    Aitziber Buqué, Norma Bloy, Fernando Aranda, Isabelle Cremer, Alexander M.M. Eggermont, Wolf H. Fridman, Jitka Palich Fucikova, Jérôme Galon, Radek Špíšek, Éric Tartour et al. · 2016 · OncoImmunology
  14. Tryptophan degradation as a systems phenomenon in inflammation – an analysis across 13 chronic inflammatory diseases
    Danielle M M Harris, Silke Szymczak, Sven Schuchardt, Johannes Labrenz, Florian Tran, Lina Welz, Hanna Graßhoff, Henner Zirpel, Melike Sümbül, Mhmd Oumari et al. · 2024 · EBioMedicine
  15. The mannose receptor negatively modulates the Toll-like receptor 4–aryl hydrocarbon receptor–indoleamine 2,3-dioxygenase axis in dendritic cells affecting T helper cell polarization
    Fabián Salazar, Laurence Hall, Ola H. Negm, Dennis Awuah, Patrick J. Tighe, Farouk Shakib, Amir M. Ghaemmaghami · 2015 · Journal of Allergy and Clinical Immunology
  16. Enhancing adoptive cancer immunotherapy with Vγ2Vδ2 T cells through pulse zoledronate stimulation
    Mohanad H. Nada, Hong Wang, Grefachew Workalemahu, Yoshimasa Tanaka, Craig T. Morita · 2017 · Journal for ImmunoTherapy of Cancer
  17. Peptide vaccination directed against IDO1-expressing immune cells elicits CD8+ and CD4+ T-cell-mediated antitumor immunity and enhanced anti-PD1 responses
    Souvik Dey, Erika Sutanto‐Ward, Katharina Kopp, James B. DuHadaway, Arpita Mondal, Dema Ghaban, Inés Lecoq, Mai-Britt Zocca, Lauren M.F. Merlo, Laura Mandik‐Nayak et al. · 2020 · Journal for ImmunoTherapy of Cancer
  18. Adipose tissue macrophages: implications for obesity-associated cancer
    Bei Li, Si Sun, Juan-Juan Li, Jing-Ping Yuan, Shengrong Sun, Qi Wu · 2023 · Military Medical Research
  19. Objective measurement and clinical significance of IDO1 protein in hormone receptor-positive breast cancer
    Daniel Carvajal‐Hausdorf, Nikita Lavanya Mani, Vamsidhar Velcheti, Kurt Alex Schalper, David L. Rimm · 2017 · Journal for ImmunoTherapy of Cancer
  20. Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases
    Fanni Annamária Boros, Zsuzsanna Bohár, László Vécsei · 2018 · Mutation Research/Reviews in Mutation Research
  21. Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response
    Roger Gilabert‐Oriol, Gemma M. Ryan, Ada W.Y. Leung, Natalie S. Firmino, Kevin L. Bennewith, Marcel B. Bally · 2018 · International Journal of Molecular Sciences
  22. Dietary tryptophan deficiency and its supplementation compromises inflammatory mechanisms and disease resistance in a teleost fish
    Marina Machado, Rita Azeredo, Andreia Domingues, Sérgio Fernández-Boo, Jorge P. Dias, Luís E. C. Conceição, Benjamín Costas · 2019 · Scientific Reports
  23. Lactate in Sarcoma Microenvironment: Much More than just a Waste Product
    Maria Letizia Taddei, Laura Pietrovito, Angela Leo, Paola Chiarugi · 2020 · Cells
  24. Effects of host‐directed therapies on the pathology of tuberculosis
    Liana Tsenova, Amit Singhal · 2020 · The Journal of Pathology
  25. Adoptive T cell therapy: Boosting the immune system to fight cancer
    E. Cintora León, Raghuveer Ranganathan, Barbara Savoldo · 2020 · Seminars in Immunology
  26. Toxoplasma Effectors that Affect Pregnancy Outcome
    David Arranz-Solís, Debanjan Mukhopadhyay, Jeroen P. J. Saeij · 2020 · Trends in Parasitology
  27. Decoding the metabolic dialogue in the tumor microenvironment: from immune suppression to precision cancer therapies
    Ruoli Wang, Jincheng Zhuang, Qi Zhang, Wantao Wu, Xinrui Yu, Hao Zhang, Zongyi Xie · 2025 · Experimental Hematology and Oncology
  28. Amino Acid Metabolism Inhibits Antibody-Driven Kidney Injury by Inducing Autophagy
    Kapil Chaudhary, Rahul Suresh Shinde, Haiyun Liu, Jaya P. Gnana‐Prakasam, Rajalakshmi Veeranan‐Karmegam, Lei Huang, Buvana Ravishankar, Jillian Bradley, Nino Kvirkvelia, Malgorzata McMenamin et al. · 2015 · The Journal of Immunology
  29. Neuroendocrine and Immune Responses Undertake Different Fates following Tryptophan or Methionine Dietary Treatment: Tales from a Teleost Model
    Rita Azeredo, Marina Machado, António Afonso, Camino Fierro-Castro, Felipe E. Reyes‐López, Lluís Tort, Manuel Gesto, Marta Conde‐Sieira, Jesús Manuel Míguez, Jose Luis Soengas et al. · 2017 · Frontiers in Immunology
  30. Indoleamine-2,3-Dioxygenase in Non–Small Cell Lung Cancer
    Ashley K. Volaric, Ryan D. Gentzler, Richard Delmar Hall, James Hunter Mehaffey, Edward B. Stelow, Timothy N. J. Bullock, Linda W. Martin, Anne M. Mills · 2018 · The American Journal of Surgical Pathology
  31. CD276 and the gene signature composed of GATA3 and LGALS3 enable prognosis prediction of glioblastoma multiforme
    Yasuo Takashima, Atsushi Kawaguchi, Azusa Hayano, Ryuya Yamanaka · 2019 · PLoS ONE
  32. Metal–ligand coordination nanomaterials for radiotherapy: emerging synergistic cancer therapy
    Lijuan Zeng, Yuhua Cao, Ling He, Shuaishuai Ding, Xiu‐Wu Bian, Gan Tian · 2020 · Journal of Materials Chemistry B
  33. The cross-talk between opportunistic fungi and the mammalian host via microbiota’s metabolism
    Romani, Luigina, Zelante, Teresa, Palmieri, Melissa, Napolioni, Valerio, Picciolini, Matteo, Velardi, Andrea, Aversa, Franco, Puccetti, Paolo · 2015 · Seminars in Immunopathology
  34. Tryptophan Metabolism Along the Kynurenine Pathway Downstream of Toll‐like Receptor Stimulation in Peripheral Monocytes
    Orhan, F., Bhat, M., Sandberg, K., Ståhl, S., Piehl, F., Karolinska Schizophrenia Project (KaSP) consortium, Svensson, C., Erhardt, S., Schwieler, L. · 2016 · Scandinavian Journal of Immunology
  35. Metabolic Checkpoints: Novel Avenues for Immunotherapy of Cancer
    Ivan Shevchenko, Alexandr V. Bazhin · 2018 · Frontiers in Immunology
  36. The ups, downs and new trends of IDO1 inhibitors
    Shulun Chen, Jing Tan, Ao Zhang · 2021 · Bioorganic Chemistry
  37. The New Era of Cancer Immunotherapy
    Danny N. Khalil, Sadna Budhu, Billel Gasmi, Roberta Zappasodi, Daniel Hirschhorn-Cymerman, Tamar Plitt, Olivier De Henau, Dmitriy Zamarin, Rikke Holmgaard, Judith T. Murphy et al. · 2015 · Advances in cancer research
  38. IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII
    Davide Matino, Marco Gargaro, Elena Santagostino, Matteo Nicola Dario Di Minno, Giancarlo Castaman, Massimo Morfini, Angiola Rocino, Maria Elisa Mancuso, Giovanni Di Minno, Antonio Coppola et al. · 2015 · Journal of Clinical Investigation
  39. The role of T helper 17 and regulatory T cells in tumor microenvironment
    Soheil Najafi, Abbas Mirshafiey · 2019 · Immunopharmacology and Immunotoxicology
  40. The distinct roles of monoamines in multiple sclerosis: A bridge between the immune and nervous systems?
    Tiziana Carandini, Mara Cercignani, Daniela Galimberti, Elio Angelo Scarpini, Marco Bozzali · 2021 · Brain Behavior and Immunity
  41. Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating Nanosuspension
    Seung Mo Jin, Sang Nam Lee, Jung Eun Kim, Yeon Jeong Yoo, Chanyoung Song, Hong Sik Shin, Hathaichanok Phuengkham, Chang Hoon Lee, Soong Ho Um, Yong Taik Lim · 2021 · Advanced Science
  42. Interferon-driven alterations of the host’s amino acid metabolism in the pathogenesis of typhoid fever
    Christoph J. Blohmke, Thomas C. Darton, Claire Jones, Nicolás M. Suárez, Claire S. Waddington, Brian Angus, Liqing Zhou, Jennifer W Hill, Simon Clare, Leanne Kane et al. · 2016 · The Journal of Experimental Medicine
  43. Type I Interferons, Autophagy and Host Metabolism in Leprosy
    Thiago Gomes de Toledo-Pinto, Leonardo Ribeiro Batista-Silva, Rychelle Clayde Affonso Medeiros, Flávio Alves Lara, Milton Ozório Moraes · 2018 · Frontiers in Immunology
  44. Folated pH-degradable nanogels for the simultaneous delivery of docetaxel and an IDO1-inhibitor in enhancing cancer chemo-immunotherapy
    Haishi Qiao, Xingmei Chen, Enping Chen, Junmei Zhang, Dechun Huang, Danqi Yang, Youchao Ding, Hongliang Qian, Jan Feijén, Wei Chen · 2019 · Biomaterials Science
  45. Preclinical investigations and a first-in-human phase I trial of M4112, the first dual inhibitor of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase 2, in patients with advanced solid tumors
    Aung Naing, Joseph P. Eder, Sarina Anne Piha-Paul, Claude D. Gimmi, Elizabeth K. Hussey, Sen Zhang, Vera Hildebrand, Vinayak P. Hosagrahara, Christina Habermehl, Jacques Moisan et al. · 2020 · Journal for ImmunoTherapy of Cancer
  46. Local Generation of Kynurenines Mediates Inhibition of Neutrophil Chemotaxis by Uropathogenic Escherichia coli
    Jennifer A. Loughman, Melanie L. Yarbrough, Kristin M. Tiemann, David A. Hunstad · 2016 · Infection and Immunity
  47. The immunometabolic role of indoleamine 2,3-dioxygenase in atherosclerotic cardiovascular disease: immune homeostatic mechanisms in the artery wall
    Daniel F.J. Ketelhuth · 2019 · Cardiovascular Research
  48. Fetomaternal Immune Tolerance: Crucial Mechanisms of Tolerance for Successful Pregnancy in Humans
    Yousef Yousefzadeh, Mohammad Sadegh Soltani‐Zangbar, Maryam Hemmatzadeh, Navid Shomali, Ata Mahmoodpoor, Javad Ahmadian Heris, Mehdi Yousefi · 2021 · Immunological Investigations
  49. Depressive-like behavior induced by tumor necrosis factor-α is attenuated by m-trifluoromethyl-diphenyl diselenide in mice
    César Augusto Brüning, Franciele Martini, Suelen Mendonça Soares, Lucielli Savegnago, Tuane Bazanella Sampaio, Cristina Wayne Nogueira · 2015 · Journal of Psychiatric Research
  50. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells
    Fang Xie, Ji Sen Cao, Jian Hua Zhao, Yang Yu, Feng Qi, Xiangchen Dai · 2015 · Transplant Immunology
  51. Indoleamine 2,3-Dioxygenase Regulates Macrophage Recruitment, Polarization and Phagocytosis in Aspergillus Fumigatus Keratitis
    Nan Jiang, Li Zhang, Guiqiu Zhao, Jing Lin, Qian Wang, Qiang Xu, Li Cui, Liting Hu, Xudong Peng, Feifei Yu et al. · 2020 · Investigative Ophthalmology & Visual Science
  52. Multi‐omic and spatial dissection of immunotherapy response groups in non‐small cell lung cancer
    James H. Monkman, Honesty Kim, Aaron T. Mayer, Ahmed Murtaza Mehdi, Nicholas Matigian, Marie Cumberbatch, Milan Bhagat, Rahul Ladwa, Scott N. Mueller, Mark N. Adams et al. · 2023 · Immunology
  53. The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza
    Anthony T. DiPiazza, Katherine A. Richards, Zackery A. G. Knowlden, Jennifer Lynn Nayak, Andrea J. Sant · 2016 · Frontiers in Immunology
  54. IDO, PTEN-expressing Tregs and control of antigen-presentation in the murine tumor microenvironment
    David H. Munn, Madhav D. Sharma, Theodore S. Johnson, Paulo C. Rodrı́guez · 2017 · Cancer Immunology Immunotherapy
  55. Preparing for cell culture scale-out: establishing parity of bioreactor- and flask-expanded mesenchymal stromal cell cultures
    R. Das, Rens Roosloot, Melissa van Pel, Koen Schepers, Marijn Driessen, Willem E. Fibbe, Joost Dick de Bruijn, Helene Roelofs · 2019 · Journal of Translational Medicine
  56. Pathogens MenTORing Macrophages and Dendritic Cells: Manipulation of mTOR and Cellular Metabolism to Promote Immune Escape
    Lonneke V. Nouwen, Bart Everts · 2020 · Cells
  57. IDO Downregulation Induces Sensitivity to Pemetrexed, Gemcitabine, FK866, and Methoxyamine in Human Cancer Cells
    Saman Maleki Vareki, Di Chen, Christine Di Cresce, Peter J. Ferguson, René Figueredo, Macarena Pampillo, Mateusz Rytelewski, Mark David Vincent, Wei‐Ping Min, Xiufen Zheng et al. · 2015 · PLoS ONE
  58. Latest developments in tryptophan metabolism: Understanding its role in B cell immunity
    Xavier Dagenais-Lussier, Hamza Loucif, Cherifa Beji, Roman Telittchenko, Jean‐Pierre Routy, Julien van Grevenynghe · 2021 · Cytokine & Growth Factor Reviews
  59. Indoleamine 2,3‐dioxygenase ( IDO )‐1 and IDO ‐2 activity and severe course of COVID ‐19
    Lihui Guo, Bernadette Schurink, Eva Roos, Esther J. Nossent, JanWillem Duitman, Alexander P. J. Vlaar, Paul van der Valk, Frédéric Maxime Vaz, Syun‐Ru Yeh, Zachary Geeraerts et al. · 2021 · The Journal of Pathology
  60. Pre-Conditioning with IFN-γ and Hypoxia Enhances the Angiogenic Potential of iPSC-Derived MSC Secretome
    Su‐Ya Wang, Felix Umrath, Wanjing Cen, António José Salgado, Siegmar Reinert, Dorothea Alexander · 2022 · Cells
  61. Impact of IDO1 and IDO2 on the B Cell Immune Response
    Lauren M.F. Merlo, Weidan Peng, Laura Mandik‐Nayak · 2022 · Frontiers in Immunology
  62. The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment
    Johanna Maria Gostner, Kathrin Becker, Florian Überall, Dietmar Fuchs · 2015 · Expert Opinion on Therapeutic Targets
  63. A Transendocytosis Perspective on the CD28/CTLA-4 Pathway
    Blagoje Soskic, Omar S. Qureshi, Tiezheng Hou, David Michael Sansom · 2014 · Advances in immunology
  64. Assessment of TILs, IDO-1, and PD-L1 in resected non-small cell lung cancer: an immunohistochemical study with clinicopathological and prognostic implications
    Martina Mandarano, Guido Bellezza, Maria Laura Belladonna, Benoit J. Van den Eynde, Rita Chiari, Jacopo Vannucci, Giada Mondanelli, Vienna Ludovini, Ivana Ferri, Fortunato Bianconi et al. · 2018 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  65. Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment
    Tiecheng Wang, Jiakang Jin, Chao Qian, Jianan Lou, Jinti Lin, Ankai Xu, Kaishun Xia, Libin Jin, Bing Liu, Huimin Tao et al. · 2021 · Cancer Cell International
  66. Cyclooxygenase-2 (COX-2) Inhibition Constrains Indoleamine 2,3-Dioxygenase 1 (IDO1) Activity in Acute Myeloid Leukaemia Cells
    Maria Grazia Iachininoto, Eugenia Rosa Nuzzolo, Giuseppina Bonanno, Andrea Mariotti, Annabella Procoli, Franco Locatelli, Raimondo DE CRISTOFARO, Sergio Rutella · 2013 · Molecules
  67. Indoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington’s Disease
    Gelareh Mazarei, Blair R. Leavitt · 2015 · Journal of Huntington s Disease
  68. Metabolic regulation of suppressive myeloid cells in cancer
    Antonio Sica, Laura Strauss, Francesca Maria Consonni, Cristina Travelli, Armando A. Genazzani, Chiara Porta · 2017 · Cytokine & Growth Factor Reviews
  69. Synovial Fibroblasts Selectively Suppress Th1 Cell Responses through IDO1-Mediated Tryptophan Catabolism
    Lars‐Oliver Tykocinski, Anna M Lauffer, Antonia Bohnen, Nathalie-Christin Kaul, Stefan Krienke, Theresa Tretter, Isabell Adam, Soumya R. Mohapatra, Philippe Saikali, Max Löhning et al. · 2017 · The Journal of Immunology
  70. FoxP3, CTLA-4, and IDO in Canine Melanocytic Tumors
    Ilaria Porcellato, Chiara Brachelente, Katia Cappelli, Laura Menchetti, Serenella Silvestri, Monica Sforna, Samanta Mecocci, Selina Iussich, Leonardo Leonardi, Luca Mechelli · 2020 · Veterinary Pathology
  71. IDO1 scavenges reactive oxygen species in myeloid-derived suppressor cells to prevent graft-versus-host disease
    Ji-Min Ju, Giri Nam, Young-Kwan Lee, Minho Jung, Hanna Chang, Woojin Kim, Woo-Jeong Shon, Ji Young Lim, Joo‐Young Kim, Jun Chang et al. · 2021 · Proceedings of the National Academy of Sciences
  72. Regulatory Macrophages and Tolerogenic Dendritic Cells in Myeloid Regulatory Cell-Based Therapies
    Maaike Suuring, Aurélie Moreau · 2021 · International Journal of Molecular Sciences
  73. Evaluation of Inflammatory Response System (IRS) and Compensatory Immune Response System (CIRS) in Adolescent Major Depression
    Nikola Ferencová, Zuzana Višňovcová, Igor Ondrejka, Dana Funakova, Igor Hrtánek, Simona Kelčíková, Ingrid Tonhajzerová · 2022 · Journal of Inflammation Research
  74. Physical Activity as the Best Supportive Care in Cancer: The Clinician’s and the Researcher’s Perspectives
    Cécile Torregrosa, Frédéric Chorin, Eva Ester Molina Beltran, Cindy Neuzillet, Victoire Cardot‐Ruffino · 2022 · Cancers
  75. The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma
    Susann Schönefeldt, Tamara Wais, Marco Herling, Satu M. Mustjoki, Vasileios Bekiaris, Richard Moriggl, Heidi Anne Neubauer · 2021 · Cancers
  76. Biomarkers for immune checkpoint inhibition in sarcomas – are we close to clinical implementation?
    Chin Sern Yiong, Tzu Ping Lin, Vivian Lim, Tan Boon Toh, Valerie Shiwen Yang · 2023 · Biomarker Research
  77. The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
    Katrien De Wolf, Karim Vermaelen, Gert De Meerleer, Bart N. Lambrecht, Piet Ost · 2015 · OncoImmunology
  78. Blockade of the B7-H1/PD-1 Pathway as a Basis for Combination Anticancer Therapy
    Mario Sznol · 2014 · The Cancer Journal
  79. Reduced CD 200 expression is associated with altered Th1/Th2 cytokine production in placental trophoblasts from preeclampsia
    Jie Xu, Yang Gu, Jingxia Sun, Hui Fang Zhu, David F. Lewis, Yuping Wang · 2017 · American Journal of Reproductive Immunology
  80. An indoleamine 2, 3-dioxygenase siRNA nanoparticle-coated and Trp2-displayed recombinant yeast vaccine inhibits melanoma tumor growth in mice
    Dong‐qun Liu, Shuai Lü, Lingxiao Louis Zhang, Mei Ji, Shuying Liu, Shaowei Wang, Rui‐tian Liu · 2018 · Journal of Controlled Release
  81. The cellular metabolic landscape in the tumor milieu regulates the activity of myeloid infiltrates
    Eslam T. Mohamed, Amir A. Al-Khami, Paulo C. Rodrı́guez · 2018 · Cellular and Molecular Immunology
  82. Aspergillus fumigatus tryptophan metabolic route differently affects host immunity
    Teresa Zelante, Tsokyi Choera, Anne Beauvais, Francesca Fallarino, Giuseppe Paolicelli, Giuseppe Pieraccini, Marco Pieroni, Claudia Galosi, Claudia Beato, Antonella DE LUCA et al. · 2021 · Cell Reports
  83. The kynurenine pathway presents multi-faceted metabolic vulnerabilities in cancer
    Ricardo A. Léon-Letelier, Rongzhang Dou, Jody V. Vykoukal, Ali Hussein Abdel Sater, Edwin Justin Ostrin, Samir Hanash, Johannes Francois Fahrmann · 2023 · Frontiers in Oncology
  84. Microbial modulation of tryptophan metabolism links gut microbiota to disease and its treatment
    Pengfei Zhao, Yuqi Chen, Shuyu Zhou, Fei Li · 2025 · Pharmacological Research
  85. Intratracheal Administration of Mesenchymal Stem Cells Modulates Tachykinin System, Suppresses Airway Remodeling and Reduces Airway Hyperresponsiveness in an Animal Model
    Konrad Urbanek, Antonella De Angelis, Giuseppe Spaziano, Elena Piegari, Maria Matteis, Donato Cappetta, Grazia Esposito, Rosa Russo, Gioia Tartaglione, Raffaele De Palma et al. · 2016 · PLoS ONE
  86. Hepatic stellate cells increase the immunosuppressive function of natural Foxp3+ regulatory T cells via IDO-induced AhR activation
    Sudhir Kumar, Jiang Wang, Angus W. Thomson, Chandrashekhar R. Gandhi · 2016 · Journal of Leukocyte Biology
  87. Strong Correlation of Indoleamine 2,3-Dioxygenase 1 Expression with Basal-Like Phenotype and Increased Lymphocytic Infiltration in Triple-Negative Breast Cancer
    Sewha Kim, Sanghui Park, Min Sun Cho, Woosung Lim, Byung‐In Moon, Sun Hee Sung · 2016 · Journal of Cancer
  88. Strategic Incorporation of Polarity in Heme-Displacing Inhibitors of Indoleamine-2,3-dioxygenase-1 (IDO1)
    Catherine White, Meredeth A. McGowan, Hua Zhou, Nunzio Sciammetta, Xavier Fradera, Jongwon Lim, Elizabeth Joshi, Christine L. Andrews, Elliott B. Nickbarg, Phillip M. Cowley et al. · 2020 · ACS Medicinal Chemistry Letters
  89. Aminoacyl-tRNA synthetase inhibition activates a pathway that branches from the canonical amino acid response in mammalian cells
    Yeonjin Kim, Mark S. Sundrud, Changqian Zhou, Maja Edenius, Davide Zocco, Kristen Powers, Miao Zhang, Ralph Mazitschek, Anjana Rao, Chang‐Yeol Yeo et al. · 2020 · Proceedings of the National Academy of Sciences
  90. Microbial modulation of intestinal T helper cell responses and implications for disease and therapy
    Markus B. Geuking, Regula Burkhard · 2020 · Mucosal Immunology
  91. Attenuation of Experimental Colitis in Glutathione Peroxidase 1 and Catalase Double Knockout Mice through Enhancing Regulatory T Cell Function
    Hyung-Ran Kim, Anbok Lee, Eun-Jeong Choi, Jeong Hae Kie, Woosung Lim, Hyeon Kook Lee, Byung-In Moon, Ju‐Young Seoh · 2014 · PLoS ONE
  92. Disturbed tryptophan metabolism correlating to progression and metastasis of esophageal squamous cell carcinoma
    Jing Cheng, Hai Dan Jin, Xiaobei Hou, Jie Lv, Xianfu Gao, Guangyong Zheng · 2017 · Biochemical and Biophysical Research Communications
  93. Tryptophan catabolites along the indoleamine 2,3-dioxygenase pathway as a biological link between depression and cancer
    Francisco Stefânio Barreto, Adriano José Maia Chaves Filho, Márcia Cristiane Araújo, Manoel O. de Moraes, Maria Elisabete Amaral de Moraes, Michael H. J. Maes, David Freitas de Lucena, Danielle S. Macêdo · 2018 · Behavioural Pharmacology
  94. Metabolic Regulation of Immune Responses to Mycobacterium tuberculosis: A Spotlight on L-Arginine and L-Tryptophan Metabolism
    Rebecca R. Crowther, Joseph E. Qualls · 2021 · Frontiers in Immunology
  95. Nanotopography reveals metabolites that maintain the immunomodulatory phenotype of mesenchymal stromal cells
    Ewan A. Ross, Lesley-Anne Turner, Hannah Donnelly, Anwer Saeed, Penelope M. Tsimbouri, Karl Burgess, Gavin J. Blackburn, Vineetha Jayawarna, Yinbo Xiao, Mariana Azevedo Gonzalez‐Oliva et al. · 2023 · Nature Communications
  96. Synthesis and in vivo antitumor evaluation of an orally active potent phosphonamidate derivative targeting IDO1/IDO2/TDO
    Xi Feng, Pei Shen, Yinuo Wang, Zhiyu Li, Jinlei Bian · 2019 · Biochemical Pharmacology
  97. Recent advances in the discovery of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors
    Xiuxiu Wang, Si-Yu Sun, Qing-Qing Dong, Xiao-xiang Wu, Wei Tang, Ya-Qun Xing · 2019 · MedChemComm
  98. GBP1 Facilitates Indoleamine 2,3-Dioxygenase Extracellular Secretion to Promote the Malignant Progression of Lung Cancer
    Yinnan Meng, Wei Wang, Meng Chen, Kuifei Chen, Xinhang Xia, Suna Zhou, Haihua Yang · 2021 · Frontiers in Immunology
  99. Cytosolic DNA sensing via the stimulator of interferon genes adaptor: Yin and Yang of immune responses to DNA
    Henrique de Paula Lemos, Lei Huang, Tracy L. McGaha, Andrew L. Mellor · 2014 · European Journal of Immunology
  100. Nutritional metabolomics in critical illness
    Kenneth B. Christopher · 2017 · Current Opinion in Clinical Nutrition & Metabolic Care